REQUEST A DEMO
Total
USD $0.00
Search more companies

Chemopharma Polska Sp. z o.o. (Poland)

Main Activities: Chemical and Allied Products Merchant Wholesalers
Full name: Chemopharma Polska Sp. z o.o. Profile Updated: April 05, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Chemopharma (Austria) operates in the food, pharmaceutical, and cosmetic industries, distributing pharmaceutical raw materials, veterinary products, cosmetics, plant extracts, nutritional supplements, and paper industry products. Chemopharma (Austria) focuses on providing products and services tailored to the needs of its target markets in Central, Eastern, and Southeastern Europe.

Headquarters
Ul. Biala 4
Warsaw; Mazowieckie; Postal Code: 00-895

Contact Details: Purchase the Chemopharma Polska Sp. z o.o. report to view the information.

Website: http://www.chemopharma.com

Basic Information
Total Employees:
Purchase the Chemopharma Polska Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Chemopharma Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Chemopharma Polska Sp. z o.o. report to view the information.
Incorporation Date:
December 18, 2001
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Chemopharma Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
34.84%
Net Profit (Loss) for the Period
15.92%
Total assets
-0.17%
Total equity
-0.17%
Return on Equity (ROE)
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?